Cochrane Review Group
Vascular
115 systematic reviews in Vascular ask 1,558 questions. 22.2% have no studies to answer them, 18% rest on very low certainty evidence and 23.4% reach moderate or high certainty.
Reviews
115
Questions
1,558
current versions
No studies
22.2%
Moderate or high
23.4%
No studies 346 · 22.2%Ungraded 90 · 5.8%Very low 281 · 18%Low 477 · 30.6%Moderate 313 · 20.1%High 51 · 3.3%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Failure of hemostatic intervention ( · vascular surgery patients who undergo creation of an anastomosis The role of sealants for achieving anastomotic hemostasis in vascular surgery (2024) · Cochrane | RR 0.46 [0.35, 0.61] | 17 studies · 2120 participants | Very low |
Intervention NR Death from bleeding complications (up to 30 days · vascular surgery patients who undergo creation of an anastomosis The role of sealants for achieving anastomotic hemostasis in vascular surgery (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Change in claudication distance from baseline (m) · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Amputation‐free survival · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Revascularisation‐free survival · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Major adverse limb events (MALE) · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Above‐ankle amputation · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane | no estimate extracted | NR | No studies |
Supervised exercise therapy following vascular intervention vs vascular intervention alone MWD ‐ change from baseline · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane | no estimate extracted | 2 studies · 89 participants | Very low |
Supervised exercise therapy following vascular intervention vs vascular intervention alone 6MWT ‐ change from baseline · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane | no estimate extracted | 1 study · 49 participants | Very low |
Supervised exercise therapy following vascular intervention vs vascular intervention alone PFWD ‐ change from baseline · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane | no estimate extracted | 2 studies · 87 participants | Very low |
Supervised exercise therapy following vascular intervention vs vascular intervention alone ABI ‐ absolute value · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane | no estimate extracted | 2 studies · 110 participants | Very low |
Supervised exercise therapy following vascular intervention vs vascular intervention alone Mortality · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane | OR 0.92 [0.42, 2] | 6 studies · 346 participants | Very low |
Reviews 115
Pentoxifylline for intermittent claudication
CochraneSoF table
5 questions
Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children
CochraneSoF table
6 questions
Vena caval filters for the prevention of pulmonary embolism
CochraneSoF table
10 questions
Atherectomy for peripheral arterial disease
CochraneSoF table
14 questions
Angioplasty versus stenting for iliac artery lesions
CochraneSoF table
7 questions
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
CochraneSoF table
70 questions
Modes of exercise training for intermittent claudication
CochraneSoF table
6 questions
Low molecular weight heparin for prevention of microvascular occlusion in digital replantation
CochraneSoF table
14 questions
Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization
CochraneSoF table
5 questions
Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity
CochraneSoF table
12 questions
Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long‐term central venous catheters in infants and children
CochraneSoF table
3 questions
Pharmacological treatment for Buerger's disease
CochraneSoF table
12 questions
Transverse versus vertical groin incision for femoral artery approach
CochraneSoF table
7 questions
Treatment of distal deep vein thrombosis
CochraneSoF table
14 questions
Compression therapy for treating post‐thrombotic syndrome
CochraneSoF table
8 questions
Clinically‐indicated replacement versus routine replacement of peripheral venous catheters
CochraneSoF table
7 questions
Endovascular versus open repair of asymptomatic popliteal artery aneurysm
CochraneSoF table
4 questions
TNF‐α blockers for the treatment of Kawasaki disease in children
CochraneSoF table
7 questions
Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the femoropopliteal arteries
CochraneSoF table
5 questions
Graduated compression stockings for prevention of deep vein thrombosis
CochraneSoF table
12 questions
Graft type for femoro‐popliteal bypass surgery
CochraneSoF table
16 questions
Surgery versus thrombolysis for initial management of acute limb ischaemia
CochraneSoF table
7 questions
Home versus in‐patient treatment for deep vein thrombosis
CochraneSoF table
7 questions
Treatment for superficial thrombophlebitis of the leg
CochraneSoF table
25 questions
Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation
CochraneSoF table
2 questions